Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Botulism

Botulism

Botulism is a life-threatening neuroparalytic condition caused by botulinum neurotoxin, which is produced by the bacterium Clostridium botulinum, a Gram-positive, spore-forming, obligate anaerobe.In adults, the toxin enters the body in different ways: in foodborne botulism, the preformed toxin is absorbed in the intestine. In wound botulism, spores grow in injured tissue and release the toxin into the blood. Infant botulism differs mechanistically from adult forms. In infants, botulism commonly...

Tetanus

Tetanus

Tetanus is a life-threatening neurological disorder characterized by persistent muscle contractions and spastic paralysis. It is caused by Clostridium tetani, a motile, Gram-positive, rod-shaped, obligate anaerobe. These bacteria produce terminal endospores, giving them a distinctive “lollipop” or “tennis-racket” appearance. They thrive in anaerobic environments, such as those found in deep puncture wounds.Once introduced into the body, the spores germinate into vegetative cells. These cells...

Diphtheria

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...

Development of Human Microbiota

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...

Bacterial Meningitis I: Introduction

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...

Bacterial Meningitis

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Gene expression dynamics in <i>Bacillus cereus</i> and <i>Bacillus subtilis</i> treated with <i>Thymus vulgaris</i> and <i>Origanum vulgare</i> subsp. <i>hirtum</i> essential oils.

Frontiers in microbiology·2025

Same author

Antimicrobial susceptibility of Clostridium botulinum group III field strains isolated in Europe from animal outbreaks.

Veterinary microbiology·2024

Same author

Lessons from a recent multicountry iatrogenic botulism outbreak.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2023

Same author

Editorial: New insights on botulism, botulinum neurotoxins, and botulinum toxin-producing clostridia.

Frontiers in microbiology·2022

Same author

Infant Botulism: Checklist for Timely Clinical Diagnosis and New Possible Risk Factors Originated from a Case Report and Literature Review.

Toxins·2021

Same author

Asymptomatic Carriage of <i>C. botulinum</i> Type D/C in Broiler Flocks as the Source of Contamination of a Massive Botulism Outbreak on a Dairy Cattle Farm.

Frontiers in microbiology·2021

Search research articles

Related Experiment Video

Updated: Jun 21, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

Infant botulism.

Lucia Fenicia¹, Fabrizio Anniballi

¹Centro Nazionale di Riferimento per il Botulismo, Dipartimento di Sanità Pubblica Veterinaria e Sicurezza Alimentare, Istituto Superiore di Sanità, Rome, Italy. lucia.fenicia@iss.it

Annali Dell'Istituto Superiore Di Sanita

|July 29, 2009

Summary

Infant botulism, a rare illness in infants under 12 months, stems from toxin-producing bacteria in the gut. Global cases highlight the need for physician awareness in diagnosing this serious condition.

Area of Science:

Pediatrics
Infectious Diseases
Microbiology

Background:

Infant botulism is a rare neuroparalytic illness affecting infants younger than 12 months.
It is caused by the absorption of botulinum toxin, produced by neurotogenic Clostridia colonizing the infant's intestinal tract.
Cases have been reported on all inhabited continents except Africa, indicating a global distribution.

Purpose of the Study:

To review the microbiological, clinical, and epidemiological characteristics of infant botulism.
To emphasize the importance of physician awareness and clinical suspicion in case recognition.

Main Methods:

This is a review article, synthesizing existing data.
Information was gathered from reported cases and scientific literature.

More Related Videos

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Related Experiment Videos

Last Updated: Jun 21, 2026

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Isolation and Quantification of Botulinum Neurotoxin From Complex Matrices Using the BoTest Matrix Assays

Published on: March 3, 2014

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

A High-throughput-compatible FRET-based Platform for Identification and Characterization of Botulinum Neurotoxin Light Chain Modulators

Published on: December 27, 2013

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Non-Invasive Model of Neuropathogenic Escherichia coli Infection in the Neonatal Rat

Published on: October 29, 2014

Main Results:

Infant botulism is caused by in situ toxin production by Clostridia in the infant gut.
Geographic distribution is widespread, excluding Africa.
Case recognition is linked to physician awareness and clinical suspicion.

Conclusions:

Infant botulism requires prompt recognition and diagnosis.
Understanding the disease's features is crucial for timely intervention.
Further awareness may improve reporting and management globally.